Frontier Capital Management CO LLC Sarepta Therapeutics, Inc. Transaction History

Frontier Capital Management CO LLC

$9.58 Billion
Q2 2024

A detailed history of Frontier Capital Management CO LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 41,199 shares of SRPT stock, worth $5.13 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

41,199

Previous 75,197 45.21%

Holding current value

$5.13 Million

Previous $9.74 Million 33.14%

% of portfolio

0.07%

Previous 0.1%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $3.85 Million - $5.57 Million	-33,998 Reduced 45.21%	41,199 $6.51 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $2.11 Million - $3.19 Million	22,570 Added 42.89%	75,197 $9.74 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $575,096 - $1.07 Million	-8,544 Reduced 13.97%	52,627 $5.07 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $4.94 Million - $5.95 Million	-48,149 Reduced 44.04%	61,171 $7.42 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $12.7 Million - $18.8 Million	-119,823 Reduced 52.29%	109,320 $12.5 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $3.83 Million - $5.08 Million	-32,555 Reduced 12.44%	229,143 $31.6 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $2.24 Million - $2.94 Million	-22,252 Reduced 7.84%	261,698 $33.9 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $12.4 Million - $19.6 Million	-164,130 Reduced 36.63%	283,950 $31.4 Million
Q2 2022 Jul 20, 2022	SELL	$62.69 - $88.44 $2.88 Million - $4.06 Million	-45,916 Reduced 9.29%	448,080 $33.6 Million
Q1 2022 Apr 14, 2022	SELL	$63.15 - $90.42 $3.81 Million - $5.45 Million	-60,327 Reduced 10.88%	493,996 $38.6 Million
Q4 2021 Jan 19, 2022	SELL	$77.28 - $99.42 $6.06 Million - $7.79 Million	-78,356 Reduced 12.38%	554,323 $49.9 Million
Q3 2021 Oct 19, 2021	BUY	$65.97 - $92.48 $1.13 Million - $1.58 Million	17,099 Added 2.78%	632,679 $58.5 Million
Q2 2021 Aug 09, 2021	BUY	$69.38 - $86.75 $42.7 Million - $53.4 Million	615,580 New	615,580 $47.9 Million
Q2 2018 Aug 03, 2018	SELL	$71.74 - $153.69 $16.4 Million - $35.1 Million	-228,640 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$54.02 - $82.27 $12.4 Million - $18.8 Million	228,640 New	228,640 $16.9 Million

Others Institutions Holding SRPT

# of Institutions

561

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Sarepta Therapeutics, Inc. Transaction History